Robert A. Anders

机构：Johns Hopkins University, Johns Hopkins Medicine, Pancreatic Cancer Action Network, Sidney Kimmel Comprehensive Cancer Center · ORCID：0000-0002-2363-9072

发表论文 725 篇 · 总被引 78059 次 · h-index 100

代表论文

Simultaneous CRISPR/Cas9-induced double-strand breaks are lethal in models of pancreatic cancer (2026 · Journal of Clinical Investigation · 被引 1)
Supplementary Data1 from A Randomized Phase II Study of Combination Atezolizumab and Varlilumab (CDX-1127) with or without Cobimetinib in Previously Treated Unresectable Biliary Tract Cancer (2026)
Data from A Randomized Phase II Study of Combination Atezolizumab and Varlilumab (CDX-1127) with or without Cobimetinib in Previously Treated Unresectable Biliary Tract Cancer (2026)
Supplementary Data2 from A Randomized Phase II Study of Combination Atezolizumab and Varlilumab (CDX-1127) with or without Cobimetinib in Previously Treated Unresectable Biliary Tract Cancer (2026)
A Randomized Phase II Study of Combination Atezolizumab and Varlilumab (CDX-1127) with or without Cobimetinib in Previously Treated Unresectable Biliary Tract Cancer (2026 · Clinical Cancer Research)
Supplementary Movie 1 from Integration of Clinical Trial Spatial Multiomics Analysis and Virtual Clinical Trials Enables Immunotherapy Response Prediction and Biomarker Discovery (2026)